Litcius/Paper detail

The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines

Marco Cavaleri, Harald Enzmann, Sabine M. J. M. Straus, Emer Cooke

2021The Lancet101 citationsDOIOpen Access PDF

Topics & Concepts

Agency (philosophy)Coronavirus disease 2019 (COVID-19)AuthorizationEuropean commissionPandemicEuropean unionMarketing authorizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineBusinessDrug approvalPolitical scienceVirologyPharmacologyInternational tradeDrugComputer scienceComputer securityBioinformaticsOutbreakInfectious disease (medical specialty)Internal medicineBiologyPhilosophyDiseaseEpistemologySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies
The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines | Litcius